文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

无糖甜味剂饮食是否有益于治疗功能性胃肠病症状?一项随机对照试验。

Is a Non-Caloric Sweetener-Free Diet Good to Treat Functional Gastrointestinal Disorder Symptoms? A Randomized Controlled Trial.

机构信息

Proteomics and Metabolomics Laboratory, Research Division, General Hospital of Mexico "Dr. Eduardo Liceaga", Mexico City 06720, Mexico.

School of High Studies in Health, La Salle University, Mexico City 14010, Mexico.

出版信息

Nutrients. 2022 Mar 5;14(5):1095. doi: 10.3390/nu14051095.


DOI:10.3390/nu14051095
PMID:35268070
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8912523/
Abstract

Background: A diet containing non-caloric sweeteners (NCS) could reduce calorie intake; conversely, some animal studies suggest that NCS consumption may increase functional gastrointestinal disorder symptoms (FGDs). This study aimed to compare the effect of consuming a diet containing NCS (c-NCS) versus a non-caloric sweetener-free diet (NCS-f) on FGDs. Methods: We conducted a randomized, controlled, parallel-group study using two different diets for five weeks: the c-NCS diet contained 50−100 mg/day NCS, whereas the NCS-f diet had less than 10 mg/day NCS. At the beginning of the study (PreTx) and at the end (PostTx), we assessed FGDs, dietary intake, and NCS consumption. Results: The percentage of participants with diarrhea (PreTx = 19% vs. PstTx = 56%; p = 0.02), post-prandial discomfort (PreTx = 9% vs. PstTx = 39%; p = 0.02), constipation (PreTx = 30% vs. PostTx = 56%; p < 0.01), and burning (PreTx = 13% vs. PostTx = 33%; p < 0.01) increased in the c-NCS diet group. Conversely, abdominal pain (PreTx = 15% vs. PostTx = 3%; p = 0.04), post-prandial discomfort (PreTx = 26% vs. PostTx = 6%; p = 0.02), burning (PreTx = 15% vs. PostTx = 0%; p = 0.02), early satiety (PreTx = 18% vs. PostTx = 3%; p < 0.01), and epigastric pain (PreTx = 38% vs. PostTx = 3%; p < 0.01) decreased in the NCS-f diet group. Conclusion: A c-NCS diet is associated with increased FGDs, including diarrhea, post-prandial discomfort, constipation, and burning or retrosternal pain. The NCS-f diet also decreased FGDs, as well as abdominal pain, post-prandial discomfort, burning or retrosternal pain, early satiety, and epigastric pain.

摘要

背景:含有非热量甜味剂 (NCS) 的饮食可以减少热量摄入;相反,一些动物研究表明,NCS 的消耗可能会增加功能性胃肠疾病症状 (FGDs)。本研究旨在比较摄入含 NCS (c-NCS) 的饮食与不含非热量甜味剂的饮食 (NCS-f) 对 FGDs 的影响。

方法:我们进行了一项随机、对照、平行组研究,使用两种不同的饮食五周:c-NCS 饮食含有 50-100 毫克/天 NCS,而 NCS-f 饮食中 NCS 的含量低于 10 毫克/天。在研究开始时(PreTx)和结束时(PostTx),我们评估了 FGDs、饮食摄入和 NCS 消耗。

结果:c-NCS 饮食组腹泻的参与者比例(PreTx = 19% vs. PstTx = 56%;p = 0.02)、餐后不适(PreTx = 9% vs. PstTx = 39%;p = 0.02)、便秘(PreTx = 30% vs. PostTx = 56%;p < 0.01)和烧灼感(PreTx = 13% vs. PostTx = 33%;p < 0.01)增加。相反,c-NCS 饮食组腹痛(PreTx = 15% vs. PostTx = 3%;p = 0.04)、餐后不适(PreTx = 26% vs. PostTx = 6%;p = 0.02)、烧灼感(PreTx = 15% vs. PostTx = 0%;p = 0.02)、早饱感(PreTx = 18% vs. PostTx = 3%;p < 0.01)和上腹痛(PreTx = 38% vs. PostTx = 3%;p < 0.01)减少。

结论:c-NCS 饮食与 FGDs 增加有关,包括腹泻、餐后不适、便秘和烧灼感或胸骨后疼痛。NCS-f 饮食还减少了 FGDs 以及腹痛、餐后不适、烧灼感或胸骨后疼痛、早饱感和上腹痛。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed1e/8912523/18b11b3380cd/nutrients-14-01095-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed1e/8912523/38609d2b83fc/nutrients-14-01095-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed1e/8912523/adc64b7badba/nutrients-14-01095-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed1e/8912523/18b11b3380cd/nutrients-14-01095-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed1e/8912523/38609d2b83fc/nutrients-14-01095-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed1e/8912523/adc64b7badba/nutrients-14-01095-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed1e/8912523/18b11b3380cd/nutrients-14-01095-g003.jpg

相似文献

[1]
Is a Non-Caloric Sweetener-Free Diet Good to Treat Functional Gastrointestinal Disorder Symptoms? A Randomized Controlled Trial.

Nutrients. 2022-3-5

[2]
Low-calorie sweetener use and energy balance: Results from experimental studies in animals, and large-scale prospective studies in humans.

Physiol Behav. 2016-10-1

[3]
Timing of Mesenchymal Stromal Cell Therapy Defines its Immunosuppressive Effects in a Rat Lung Transplantation Model.

Cell Transplant. 2023

[4]
The Role of Dynamic Contrast-Enhanced Magnetic Resonance Imaging in Predicting Treatment Response for Cervical Cancer Treated with Concurrent Chemoradiotherapy.

Cancer Manag Res. 2021-8-4

[5]
Use of table sugar and non-caloric sweeteners in Brazil: associated factors and changes across a decade.

Br J Nutr. 2024-5-14

[6]
Effect of Non- and Low-Caloric Sweeteners on Substrate Oxidation, Energy Expenditure, and Catecholamines in Humans-A Systematic Review.

Nutrients. 2023-6-11

[7]
Blood oxygenation level-dependent MR imaging as a predictor of therapeutic response to concurrent chemoradiotherapy in cervical cancer: a preliminary experience.

Eur Radiol. 2014-7

[8]
A randomized controlled trial contrasting the effects of 4 low-calorie sweeteners and sucrose on body weight in adults with overweight or obesity.

Am J Clin Nutr. 2019-5-1

[9]
Frequency and features of myasthenia gravis developing after thymectomy.

Eur J Neurol. 2019-8-12

[10]
The Impact of Caloric and Non-Caloric Sweeteners on Food Intake and Brain Responses to Food: A Randomized Crossover Controlled Trial in Healthy Humans.

Nutrients. 2018-5-15

引用本文的文献

[1]
Food Additives: Emerging Detrimental Roles on Gut Health.

FASEB J. 2025-7-15

[2]
Nutrition in Inflammatory Bowel Disease: Strategies to Improve Prognosis and New Therapeutic Approaches.

Diseases. 2025-5-1

[3]
Artificially Sweetened Food Mediates the Perception of Chronic Pain in Individuals With Neuroticism Traits: A Mendelian Randomization Study.

Brain Behav. 2025-4

[4]
Retrospective Cohort Study Demonstrates Tolerance and Adherence to Pea-Based Complete Enteral Formula When Transitioned from a Previous Hypoallergenic Product.

Nutrients. 2024-10-3

[5]
Editorial: Noncaloric artificial sweeteners and their impact on human health.

Front Nutr. 2024-8-19

[6]
Unveiling the profound influence of sucralose on metabolism and its role in shaping obesity trends.

Front Nutr. 2024-7-2

[7]
Coffee, Alcohol, and Artificial Sweeteners Have Temporal Associations with Gastrointestinal Symptoms.

Dig Dis Sci. 2024-7

[8]
Ultra-processed foods and food additives in gut health and disease.

Nat Rev Gastroenterol Hepatol. 2024-6

[9]
The Efficacy of Dietary Interventions in Patients with Gastroesophageal Reflux Disease: A Systematic Review and Meta-Analysis of Intervention Studies.

Nutrients. 2024-2-5

[10]
Newborns from Mothers Who Intensely Consumed Sucralose during Pregnancy Are Heavier and Exhibit Markers of Metabolic Alteration and Low-Grade Systemic Inflammation: A Cross-Sectional, Prospective Study.

Biomedicines. 2023-2-21

本文引用的文献

[1]
Ten-Week Sucralose Consumption Induces Gut Dysbiosis and Altered Glucose and Insulin Levels in Healthy Young Adults.

Microorganisms. 2022-2-14

[2]
Nutritional Components in Western Diet Versus Mediterranean Diet at the Gut Microbiota-Immune System Interplay. Implications for Health and Disease.

Nutrients. 2021-2-22

[3]
Functional gastrointestinal disorders: advances in understanding and management.

Lancet. 2020-11-21

[4]
The Effectiveness of Synbiotic Preparation Containing and Probiotic Strains and Short Chain Fructooligosaccharides in Patients with Diarrhea Predominant Irritable Bowel Syndrome-A Randomized Double-Blind, Placebo-Controlled Study.

Nutrients. 2020-7-5

[5]
Nutritional Status and Bone Microarchitecture in a Cohort of Systemic Sclerosis Patients.

Nutrients. 2020-6-1

[6]
Non-nutritive Sweeteners and Their Associations with Obesity and Type 2 Diabetes.

J Obes Metab Syndr. 2020-6-30

[7]
Nutritional status, sarcopenia, gastrointestinal symptoms and quality of life after gastrectomy for cancer - A cross-sectional pilot study.

Clin Nutr ESPEN. 2020-6

[8]
Gastrin secretion in normal subjects and diabetes patients is inhibited by glucagon-like peptide 1: a role in the gastric side effects of GLP-1-derived drugs?

Scand J Gastroenterol. 2019-12

[9]
Review of the scientific evidence and technical opinion on noncaloric sweetener consumption in gastrointestinal diseases.

Rev Gastroenterol Mex (Engl Ed). 2019

[10]
Effects of Sweeteners on the Gut Microbiota: A Review of Experimental Studies and Clinical Trials.

Adv Nutr. 2019-1-1

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索